Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Firmware Updates and OEM Proprietary Software Support

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541512 - Computer Systems Design ServicesView NAICS

Place of Performance

MD

Set-Aside

SBA

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Perform firmware updates and diagnostics using OEM-authorized software tools to ensure blower control systems are current, secure, and fully functional, including validation and reporting.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541715
New
Federal
CDRH Clinical Study Service ContractThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is soliciting commercial clinical study services under solicitation number 75F40126Q00193, with proposals due by August 4, 2026. The contract is a Firm Fixed Price (FFP) award for remote performance of a clinical study involving the collection, annotation, and delivery of 12-lead ECG data from 150 subjects in the base year and 35 subjects per optional year, alongside the development of a synthetic retrospective dataset of at least 4,000 subjects to support the validation of an FDA-developed ECG signal transformation framework for AI/ML-enabled cardiovascular devices. Performance is scheduled to begin September 30, 2026, with up to four one-year optional extensions through September 29, 2031. All deliverables, including approved study protocols, de-identified datasets, monthly progress reports, and a final public-ready dataset, must comply with FDA and IRB requirements, HIPAA standards for de-identification, and FDA-approved data collection procedures. The contract requires continuous monitoring of signal quality, synchronization of FDA-approved ECG devices, and collection of comprehensive metadata during resting, supine conditions. Offerors must demonstrate extensive experience in AI and machine learning applications for 10 or more years, a proven history analyzing wearable datasets, affiliation with a hospital within 10 miles of Silver Spring, Maryland, and a track record of conducting at least five clinical studies involving both healthy and unhealthy subjects, including publications in prestigious journals. Proposals must be submitted electronically via email to Natalie.Brown@fda.hhs.gov by the deadline, formatted into two volumes: a Technical Approach detailing methodology and personnel resumes, and a Price volume using the provided attached Price Sheet, which currently contains no populated values. All offerors must have an active UEI in SAM.gov, maintain compliance with employment eligibility, anti-trafficking, and cybersecurity regulations, and adhere to clauses covering whistleblower protections, subcontractor exclusions, paid sick leave, and data safeguarding. Payment must be processed exclusively through the U.S. Treasury’s Invoice Processing Platform, with no physical delivery or FOB terms applicable. The government will evaluate proposals based on technical merit and overall advantage, not solely on price, and will select the offeror best positioned to deliver high-quality, compliant clinical data under strict oversight. Security clearances are not required, but robust data protection measures
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
Dynamic Light Scattering System (Microplastics and Nanoparticles)The U.S. Food and Drug Administration is seeking information from potential suppliers for a Dynamic Light Scattering system to support the analysis of nano-sized particles in food and color additives, with a focus on detecting and characterizing microplastics and nanoplastics. The instrument must accurately measure particle size, size distribution, zeta potential, electrophoretic mobility, concentration, refractive index, sedimentation, transmittance, molecular weight, and microrheology across the 1–1000 nm range to enable comprehensive characterization of dispersed materials in complex food matrices. This capability is critical to advancing the agency’s mission in evaluating the safety of engineered or incidental nanomaterials present in the food supply. The solicitation, identified as HPF-2026-134655, is posted under NAICS code 334516 and is issued by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. Responses are due by July 31, 2026, at 4:00 p.m. Eastern Time, and the contracting office is located in Rockville, Maryland, with performance expected in College Park, Maryland. David Seid serves as the primary point of contact for inquiries, reachable via email or phone, and all submissions must align with the technical requirements outlined to ensure compatibility with the FDA’s analytical needs for food safety research and regulatory oversight.
Analytical Laboratory Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 334516
New
Federal
iCAP-TQ additional gas module (Toxic Elements)The FDA Office of Chemistry and Toxicology, through its Division of Bioanalytical Chemistry and Chemical Contaminants Branch, is seeking to procure a gas module to be integrated with an existing Thermo Fisher iCAP TQ ICP-MS instrument to enhance the detection and quantification of toxic and nutritional elements in foods and dietary supplements. The module, which includes a 1000 mL/min mass flow controller and associated software modifications to the Qtegra platform, is designed to improve analytical stability by reducing matrix effects in high-dissolved-solid samples. The contractor must deliver a newly manufactured, non-refurbished system and perform onsite installation, calibration, and comprehensive user training. All deliverables must meet strict technical specifications outlined in the Statement of Work, including successful auto-tune verification using the dilution gas, and are subject to a 12-month original manufacturer warranty covering parts and labor. Performance will be conducted at the FDA/HFP Laboratory Facility in College Park, Maryland, with acceptance occurring at the destination under F.O.B. destination terms, and title to the Government transfers only upon formal acceptance. The solicitation is conducted as a Lowest Priced Technically Acceptable (LPTA) procurement, meaning only technically acceptable offers will be considered for award, and the contract will be granted to the lowest-priced responsive submission without tradeoffs between cost and non-cost factors. Proposals must be submitted electronically in two volumes—Technical and Business/Price—via email to Nam Nguyen by the deadline of July 22, 2026, and must be in Microsoft Office format without macros or executable content, with any non-compliance resulting in non-responsiveness. Payment must be requested exclusively through the U.S. Treasury’s Invoice Processing Platform (IPP), and paper invoices are prohibited unless explicitly authorized. The Period of Performance spans 12 months from September 30, 2026, through September 29, 2027. The contract type is anticipated to be Firm-Fixed-Price, with no option periods, no security clearance requirements, and no organizational conflict of interest clauses. Service engineers must be certified by the original manufacturer and authorized to use proprietary diagnostic tools. All submissions are subject to SAM registration requirements, and the contract incorporates federal and HHS-specific clauses including electronic invoicing, inspection and acceptance, and government delay of work provisions.
Analytical Laboratory Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 3 days
View Details